Evaluation of the Efficacy of ROPIVACAINE in Children and Young Adults With Hereditary Epidermolysis Bullosa
Status:
Completed
Trial end date:
2019-11-28
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether topical application of Ropivacaine is
effective for treating refractory pain during dressing changes and so improve quality of life
of patients (newborn, child, adolescent or adults under 21) suffering from hereditary
epidermal epidermolysis bullosa.